Company Filing History:
Years Active: 2005
Title: The Innovations of Raymond C Koehler
Introduction
Raymond C Koehler is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of diseases related to mammalian glutamine synthetase inhibition. His innovative work has led to the development of a unique dosage form that has the potential to improve patient outcomes.
Latest Patents
Koehler holds a patent for a dosage form of L-Methionine S-Sulfoximine. This patent outlines methods for treating diseases susceptible to the inhibition of mammalian glutamine synthetase and progressive hyperammonemic encephalopathy. The patent specifies that L-methionine S-sulfoxime should be administered at a dose not to exceed 10 mg/kg body weight, with preferred dosages being lower, ideally not exceeding 2.5 mg/kg.
Career Highlights
Throughout his career, Koehler has been associated with Mso Pharma LLC, where he has been able to apply his innovative ideas in a practical setting. His work has not only contributed to the scientific community but has also paved the way for advancements in therapeutic treatments.
Collaborations
Koehler has collaborated with esteemed colleagues such as Saul W Brusilow and Richard J Traystman. These partnerships have enhanced his research and development efforts, leading to more comprehensive solutions in the medical field.
Conclusion
Raymond C Koehler's contributions to the field of medicine through his innovative patent demonstrate his commitment to improving health outcomes. His work continues to inspire future advancements in treatment methodologies.